Arabian International Healthcare Holding Company

SASE:9530 Stock Report

Market Cap: ر.س835.1m

Arabian International Healthcare Holding Past Earnings Performance

Past criteria checks 1/6

Arabian International Healthcare Holding's earnings have been declining at an average annual rate of -30.6%, while the Healthcare industry saw earnings growing at 11.9% annually. Revenues have been growing at an average rate of 27.2% per year. Arabian International Healthcare Holding's return on equity is 11%, and it has net margins of 3.2%.

Key information

-30.6%

Earnings growth rate

-196.9%

EPS growth rate

Healthcare Industry Growth12.3%
Revenue growth rate27.2%
Return on equity11.0%
Net Margin3.2%
Last Earnings Update30 Jun 2023

Recent past performance updates

Recent updates

Here's What's Concerning About Arabian International Healthcare Holding's (TADAWUL:9530) Returns On Capital

Mar 22
Here's What's Concerning About Arabian International Healthcare Holding's (TADAWUL:9530) Returns On Capital

Calculating The Fair Value Of Arabian International Healthcare Holding Company (TADAWUL:9530)

Aug 30
Calculating The Fair Value Of Arabian International Healthcare Holding Company (TADAWUL:9530)

Revenue & Expenses Breakdown
Beta

How Arabian International Healthcare Holding makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SASE:9530 Revenue, expenses and earnings (SAR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 23743241170
31 Mar 23693251130
31 Dec 22643261090
30 Sep 2261441960
30 Jun 2258557830
31 Mar 2260269780
31 Dec 2161982730
30 Sep 21746107860
30 Jun 21874132980
31 Mar 21846114990
31 Dec 20819961000
31 Dec 19697411100

Quality Earnings: 9530 has high quality earnings.

Growing Profit Margin: 9530's current net profit margins (3.2%) are lower than last year (9.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 9530's earnings have declined by 30.6% per year over the past 5 years.

Accelerating Growth: 9530's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 9530 had negative earnings growth (-58.2%) over the past year, making it difficult to compare to the Healthcare industry average (23.9%).


Return on Equity

High ROE: 9530's Return on Equity (11%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.